An emerging role of inflammasomes in spinal cord injury and spinal cord tumor

J Chen, Y Shen, X Shao, W Wu - Frontiers in Immunology, 2023 - frontiersin.org
Spinal cord injury (SCI) and spinal cord tumor are devastating events causing structural and
functional impairment of the spinal cord and resulting in high morbidity and mortality; these …

Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies

AZ Mehrabadi, F Shahba, H Khorramdelazad… - Critical Reviews in …, 2024 - Elsevier
IL-1, plays a role in some pathological inflammatory conditions. This pro-inflammatory
cytokine also has a crucial role in tumorigenesis and immune responses in the tumor …

[HTML][HTML] Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophils in pancreatic cancer

B Zhang, J Sun, H Guan, H Guo, B Huang… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
Pancreatic cancer, one of the most prevalent tumors of the digestive system, has a dismal
prognosis. Cancer of the pancreas is distinguished by an inflammatory tumor …

Interleukin-1 receptor antagonist: An alternative therapy for cancer treatment

Z Fang, J Jiang, X Zheng - Life Sciences, 2023 - Elsevier
The interleukin-1 receptor antagonist (IL-1Ra) is an anti-inflammatory cytokine and a
naturally occurring antagonist of the IL-1 receptor. It effectively counteracts the IL-1 signaling …

A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments

I Pérez-Díez, Z Andreu, MR Hidalgo… - Cancers, 2023 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with
a few curative options. Desmoplastic stroma and immune system evasion in PDAC …

Epigenetic regulation and therapeutic targets in the tumor microenvironment

Z Xie, Z Zhou, S Yang, S Zhang, B Shao - Molecular Biomedicine, 2023 - Springer
The tumor microenvironment (TME) is crucial to neoplastic processes, fostering proliferation,
angiogenesis and metastasis. Epigenetic regulations, primarily including DNA and RNA …

In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector …

S Brugiapaglia, S Bulfamante, C Curcio… - Frontiers in …, 2024 - frontiersin.org
Introduction Pancreatic Ductal Adenocarcinoma (PDA) is one of the most aggressive
malignancies with a 5-year survival rate of 13%. Less than 20% of patients have a …

Pancreatic stellate cells and the interleukin family: Linking fibrosis and immunity to pancreatic ductal adenocarcinoma

H Li, D Liu, K Li, Y Wang… - Molecular Medicine …, 2024 - spandidos-publications.com
Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive form of cancer with a
low survival rate. A successful treatment strategy should not be limited to targeting cancer …

Role of interleukins in pancreatic cancer: a literature review

S Rafaqat, H Khurshid, R Hafeez, M Arif, A Zafar… - Journal of …, 2024 - Springer
Purpose This review article summarizes the pathophysiological aspects of interleukins (ILs)
including IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, and IL-10 in pancreatic cancer (PC) …

Sex Differences in the Systemic and Local Immune Response of Pancreatic Cancer Patients

A Ahmed, S Köhler, R Klotz, N Giese, T Hackert… - Cancers, 2023 - mdpi.com
Simple Summary Sex is a factor that affects how the immune system works in both healthy
and sick people. There are differences between females and males in various aspects of …